Overview Neoadjuvant Triprizumab and Radiotherapy in Operable Patients With Stage IIA-IIIA Non-small Cell Lung Cancer Status: Recruiting Trial end date: 2026-05-30 Target enrollment: Participant gender: Summary Neoadjuvant Triprizumab and Radiotherapy in Operable Patients With Stage IIA-IIIA Non-small Cell Lung Cancer Phase: Phase 2 Details Lead Sponsor: Northern Jiangsu People's HospitalCollaborator: Shanghai Junshi Bioscience Co., Ltd.